This protocol covers the initial treatment of gastric MALT lymphoma. It applies across all cases — regardless of H. pylori infection status or disease stage at presentation.
Success is defined by confirmed H. pylori eradication, verified by urea breath test at least six weeks after completing therapy, together with regression of macroscopic gastric lesions at control endoscopy and histological regression of lymphocytic infiltration of the gastric mucosa.
H. pylori eradication therapy is the universal first step, applied in all cases. The specific antibiotic regimen is determined by clarithromycin susceptibility and whether antimicrobial susceptibility testing is feasible — the complete protocol details each pathway and its conditions.
DOI: 10.3390/cancers15153811